 |
市場調查報告書
商品編碼
1392250
全球細胞重編程市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測Global Cell Reprogramming Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
||||||
全球細胞重編程市場需求預計將從 2022 年的 364.95 萬美元達到 2030 年近 738.47 萬美元的市場規模，2023-2030 年研究期間CAGR為 9.21%。
細胞重編程是指將成熟或特化細胞的身份或特性改變回特化程度較低的狀態，通常是多能或幹細胞樣狀態的過程。這個過程需要修改細胞的基因表現模式並重新編程其命運，使其能夠恢復分化為各種細胞類型的能力。
市場動態：
細胞重編程市場的成長是由生物醫學創新前沿的多種因素所推動的。再生醫學的進步以及誘導多能幹細胞 (iPSC) 產生用於組織再生的各種細胞類型的潛力推動了市場的擴張。慢性病發病率的增加促進了對源自重編程細胞的個人化細胞療法的需求，為心血管疾病、神經退化性疾病和糖尿病等疾病提供潛在的治療方法。此外，細胞重編程有助於使用患者特異性細胞創建疾病模型，有助於藥物開發和篩選。不斷的技術進步，包括改進的重編程技術和基因組編輯工具，提高了精確度和效率，並擴大了細胞重編程的應用。產業參與者、政府資助和不斷發展的監管框架之間的合作進一步塑造了市場，影響研究、創新和商業化工作。這些共同因素強調了細胞重編程在推廣再生醫學、疾病理解和個人化治療方面的重要性，並有望對生物醫學研究和醫療保健產生重大影響。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球細胞重編程市場的每個細分市場進行了包容性評估。細胞重編程產業的成長和趨勢為這項研究提供了整體方法。
區域分析：
本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲細胞重編程市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。細胞重編程市場的主要參與者包括 Thermo Fisher Scientific, Inc.、Allele Biotech、Alstem、Stemcell Technologies Inc.、Merck KGaA、Bio-Techne、REPROCELL、Lonza、FUJIFILM Corp. (Fujifilm Cellular Dynamics)、Mogrify Ltd.。這部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
目錄
第 1 章：前言
- 報告說明
- 客觀的
- 目標受眾
- 獨特的銷售主張 (USP) 和產品
- 研究範圍
- 研究方法論
- 市場研究過程
- 市場研究方法論
第 2 章：執行摘要
- 市場亮點
- 全球市場概況
第 3 章：細胞重編程 - 產業分析
- 簡介 - 市場動態
- 市場促進因素
- 市場限制
- 機會
- 產業動態
- 波特五力分析
- 市場吸引力分析
- 按技術分類的市場吸引力分析
- 市場吸引力分析：依應用分類
- 按最終用途分類的市場吸引力分析
- 市場吸引力分析：按地區
第 4 章：價值鏈分析
- 價值鏈分析
- 原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
- 潛在買家名單
- 行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢
第 5 章：全球細胞重編程市場分析：依技術分類
- 依技術概述
- 歷史和預測數據
- 依技術分析
- 基於仙台病毒的重編程
- mRNA重編程
- 遊離重編程
- 其他
第 6 章：全球細胞重編程市場分析：依應用分類
- 概述：按應用
- 歷史和預測數據
- 分析：按應用
- 研究
- 治療性
第 7 章：全球細胞重編程市場分析：依最終用途分類
- 按最終用途分類的概述
- 歷史和預測數據
- 按最終用途分析
- 研究與學術機構
- 生技與製藥公司
第 8 章：全球細胞重編程市場分析：依地理位置
- 區域展望
- 介紹
- 北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
- 歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
- 亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
- 拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
- 中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析
第 9 章：細胞重編程公司的競爭格局
- 細胞重編程市場競爭
- 夥伴關係/協作/協議
- 併購
- 新產品發布
- 其他發展
第 10 章：公司簡介
- 公司股份分析
- 市場集中度
- Thermo Fisher Scientific Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Allele Biotech
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Alstem
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Stemcell Technologies Inc.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Merck KGaA
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Bio-Techne
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- REPROCELL
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Lonza
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- FUJIFILM Corp. (Fujifilm Cellular Dynamics)
- 公司簡介
- 公司收入
- 產品
- 最近的發展
- Mogrify Ltd.
- 公司簡介
- 公司收入
- 產品
- 最近的發展
注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內
The global demand for Cell Reprogramming Market is presumed to reach the market size of nearly USD 738.47 MN by 2030 from USD 364.95 MN in 2022 with a CAGR of 9.21% under the study period 2023 - 2030.
Cell reprogramming refers to the process of changing the identity or properties of a mature or specialized cell back to a less specialized state, typically to a pluripotent or stem cell-like state. This procedure entails modifying the gene expression patterns of a cell and reprogramming its destiny, enabling it to recover the capability to differentiate into various cell types.
MARKET DYNAMICS:
The Cell reprogramming market's growth is driven by diverse factors at the forefront of biomedical innovation. Advances in regenerative medicine and the potential of induced pluripotent stem cells (iPSCs) to generate various cell types for tissue regeneration propel market expansion. The increasing incidence of chronic diseases fosters demand for personalized cell-based therapies derived from reprogrammed cells, offering potential treatments for conditions like cardiovascular diseases, neurodegenerative disorders, and diabetes. Moreover, cell reprogramming facilitates the creation of disease models using patient-specific cells, aiding drug development and screening. Ongoing technological advancements, including improved reprogramming techniques and genome editing tools, enhance precision and efficiency, widening the applications of cell reprogramming. Collaborations between industry players, government funding, and evolving regulatory frameworks further shape the market, influencing research, innovation, and commercialization efforts. These collective factors underscore the significance of cell reprogramming in advancing regenerative medicine, disease understanding, and personalized therapies, promising substantial impact in biomedical research and healthcare.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell reprogramming. The growth and trends of cell reprogramming industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the cell reprogramming market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Technology
- Sendai Virus-Based Reprogramming
- mRNA Reprogramming
- Episomal Reprogramming
- Others
By Application
- Research
- Therapeutic
By End-Use
- Research & Academic Institutes
- Biotechnology & Pharmaceutical Companies
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the Cell Reprogramming market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Reprogramming market include Thermo Fisher Scientific, Inc., Allele Biotech, Alstem, Stemcell Technologies Inc., Merck KGaA, Bio-Techne, REPROCELL, Lonza, FUJIFILM Corp. (Fujifilm Cellular Dynamics), Mogrify Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . CELL REPROGRAMMING - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY TECHNOLOGY
- 5.1 Overview by Technology
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Technology
- 5.4 Sendai Virus-based Reprogramming Historic and Forecast Sales by Regions
- 5.5 mRNA Reprogramming Historic and Forecast Sales by Regions
- 5.6 Episomal Reprogramming Historic and Forecast Sales by Regions
- 5.7 Others Historic and Forecast Sales by Regions
6 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY APPLICATION
- 6.1 Overview by Application
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Application
- 6.4 Research Historic and Forecast Sales by Regions
- 6.5 Therapeutic Historic and Forecast Sales by Regions
7 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY END-USE
- 7.1 Overview by End-use
- 7.2 Historical and Forecast Data
- 7.3 Analysis by End-use
- 7.4 Research & Academic Institutes Historic and Forecast Sales by Regions
- 7.5 Biotechnology & Pharmaceutical Companies Historic and Forecast Sales by Regions
8 . GLOBAL CELL REPROGRAMMING MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE CELL REPROGRAMMING COMPANIES
- 9.1. Cell Reprogramming Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF CELL REPROGRAMMING INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Thermo Fisher Scientific Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. Allele Biotech
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Alstem
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Stemcell Technologies Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Merck KGaA
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Bio-Techne
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. REPROCELL
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Lonza
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. FUJIFILM Corp. (Fujifilm Cellular Dynamics)
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. Mogrify Ltd.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Technology (USD MN)
- Sendai Virus-based Reprogramming Market Sales by Geography (USD MN)
- mRNA Reprogramming Market Sales by Geography (USD MN)
- Episomal Reprogramming Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis Market by Application (USD MN)
- Research Market Sales by Geography (USD MN)
- Therapeutic Market Sales by Geography (USD MN)
- Analysis by End-use (USD MN)
- Research & Academic Institutes Market Sales by Geography (USD MN)
- Biotechnology & Pharmaceutical Companies Market Sales by Geography (USD MN)
- Global Cell Reprogramming Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Cell Reprogramming Report
- Market Research Process
- Market Research Methodology
- Global Cell Reprogramming Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Technology
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by End-use
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Technology (USD MN)
- Sendai Virus-based Reprogramming Market Sales by Geography (USD MN)
- mRNA Reprogramming Market Sales by Geography (USD MN)
- Episomal Reprogramming Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Research Market Sales by Geography (USD MN)
- Therapeutic Market Sales by Geography (USD MN)
- Global Market Analysis by End-use (USD MN)
- Research & Academic Institutes Market Sales by Geography (USD MN)
- Biotechnology & Pharmaceutical Companies Market Sales by Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
